BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Bu J, Lee TH, Jeong WJ, Poellmann MJ, Mudd K, Eun HS, Liu EW, Hong S, Hyun SH. Enhanced detection of cell-free DNA (cfDNA) enables its use as a reliable biomarker for diagnosis and prognosis of gastric cancer. PLoS One 2020;15:e0242145. [PMID: 33264292 DOI: 10.1371/journal.pone.0242145] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 2.0] [Reference Citation Analysis]
Number Citing Articles
1 Bu J, Lee TH, Poellmann MJ, Rawding PA, Jeong WJ, Hong RS, Hyun SH, Eun HS, Hong S. Tri-modal liquid biopsy: Combinational analysis of circulating tumor cells, exosomes, and cell-free DNA using machine learning algorithm. Clin Transl Med 2021;11:e499. [PMID: 34459134 DOI: 10.1002/ctm2.499] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Lee TH, Park E, Goh YG, Lee HB, Rou WS, Eun HS. The Specific Gravity-Free Method for the Isolation of Circulating Tumor KRAS Mutant DNA and Exosome in Colorectal Cancer. Micromachines (Basel) 2021;12:987. [PMID: 34442609 DOI: 10.3390/mi12080987] [Reference Citation Analysis]
3 Yuwono NL, Warton K, Ford CE. The influence of biological and lifestyle factors on circulating cell-free DNA in blood plasma. Elife 2021;10:e69679. [PMID: 34752217 DOI: 10.7554/eLife.69679] [Reference Citation Analysis]
4 Karamitrousis E, Balgkouranidou I, Xenidis N, Amarantidis K, Biziota E, Koukaki T, Kakolyris S. Concentration of circulating tumour DNA in patients with metastatic gastric cancer and its prognostic significance. Forum of Clinical Oncology 2022;0. [DOI: 10.2478/fco-2021-0010] [Reference Citation Analysis]
5 Udomruk S, Orrapin S, Pruksakorn D, Chaiyawat P. Size distribution of cell-free DNA in oncology. Crit Rev Oncol Hematol 2021;166:103455. [PMID: 34464717 DOI: 10.1016/j.critrevonc.2021.103455] [Reference Citation Analysis]
6 Rawding PA, Bu J, Wang J, Kim DW, Drelich AJ, Kim Y, Hong S. Dendrimers for cancer immunotherapy: Avidity-based drug delivery vehicles for effective anti-tumor immune response. Wiley Interdiscip Rev Nanomed Nanobiotechnol 2021;:e1752. [PMID: 34414690 DOI: 10.1002/wnan.1752] [Reference Citation Analysis]